vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and PagerDuty, Inc. (PD). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $124.5M, roughly 1.2× PagerDuty, Inc.). PagerDuty, Inc. runs the higher net margin — 129.7% vs 7.8%, a 121.9% gap on every dollar of revenue. On growth, PagerDuty, Inc. posted the faster year-over-year revenue change (4.7% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $24.1M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 5.9%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
NUTX vs PD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $124.5M |
| Net Profit | $11.8M | $161.6M |
| Gross Margin | 30.4% | 85.3% |
| Operating Margin | 20.4% | 6.5% |
| Net Margin | 7.8% | 129.7% |
| Revenue YoY | -41.1% | 4.7% |
| Net Profit YoY | -80.8% | 2827.7% |
| EPS (diluted) | $2.34 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $124.5M | ||
| Q3 25 | $267.8M | $123.4M | ||
| Q2 25 | $244.0M | $119.8M | ||
| Q1 25 | $211.8M | $121.4M | ||
| Q4 24 | $257.6M | $118.9M | ||
| Q3 24 | $78.8M | $115.9M | ||
| Q2 24 | $76.1M | $111.2M | ||
| Q1 24 | $67.5M | $111.1M |
| Q4 25 | $11.8M | $161.6M | ||
| Q3 25 | $55.4M | $9.6M | ||
| Q2 25 | $-17.7M | $-7.2M | ||
| Q1 25 | $21.2M | $-8.8M | ||
| Q4 24 | $61.6M | $-5.9M | ||
| Q3 24 | $-8.8M | $-10.9M | ||
| Q2 24 | $-364.0K | $-17.1M | ||
| Q1 24 | $-364.0K | $-28.2M |
| Q4 25 | 30.4% | 85.3% | ||
| Q3 25 | 57.8% | 84.6% | ||
| Q2 25 | 51.2% | 84.0% | ||
| Q1 25 | 55.9% | 83.6% | ||
| Q4 24 | 55.0% | 83.0% | ||
| Q3 24 | 27.8% | 82.7% | ||
| Q2 24 | 29.7% | 82.6% | ||
| Q1 24 | 15.1% | 81.7% |
| Q4 25 | 20.4% | 6.5% | ||
| Q3 25 | 48.7% | 2.9% | ||
| Q2 25 | 13.8% | -8.6% | ||
| Q1 25 | 38.1% | -9.6% | ||
| Q4 24 | 44.4% | -8.7% | ||
| Q3 24 | 12.3% | -13.8% | ||
| Q2 24 | 7.0% | -19.5% | ||
| Q1 24 | 2.1% | -30.1% |
| Q4 25 | 7.8% | 129.7% | ||
| Q3 25 | 20.7% | 7.8% | ||
| Q2 25 | -7.3% | -6.0% | ||
| Q1 25 | 10.0% | -7.2% | ||
| Q4 24 | 23.9% | -5.0% | ||
| Q3 24 | -11.2% | -9.4% | ||
| Q2 24 | -0.5% | -15.4% | ||
| Q1 24 | -0.5% | -25.3% |
| Q4 25 | $2.34 | $1.69 | ||
| Q3 25 | $7.76 | $0.10 | ||
| Q2 25 | $-2.95 | $-0.07 | ||
| Q1 25 | $3.33 | $-0.12 | ||
| Q4 24 | $11.56 | $-0.07 | ||
| Q3 24 | $-1.72 | $-0.14 | ||
| Q2 24 | $-0.07 | $-0.26 | ||
| Q1 24 | $-0.08 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $547.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $320.5M |
| Total Assets | $918.5M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $547.8M | ||
| Q3 25 | $166.0M | $567.9M | ||
| Q2 25 | $96.7M | $597.1M | ||
| Q1 25 | $84.7M | $570.8M | ||
| Q4 24 | $40.6M | $542.2M | ||
| Q3 24 | $46.9M | $599.3M | ||
| Q2 24 | $40.8M | $592.8M | ||
| Q1 24 | $30.0M | $571.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $484.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $489.5M |
| Q4 25 | $329.4M | $320.5M | ||
| Q3 25 | $317.2M | $180.7M | ||
| Q2 25 | $235.3M | $145.7M | ||
| Q1 25 | $176.9M | $129.8M | ||
| Q4 24 | $132.4M | $111.6M | ||
| Q3 24 | $60.4M | $164.7M | ||
| Q2 24 | $62.7M | $174.0M | ||
| Q1 24 | $63.0M | $171.6M |
| Q4 25 | $918.5M | $1.0B | ||
| Q3 25 | $964.5M | $891.5M | ||
| Q2 25 | $841.0M | $926.8M | ||
| Q1 25 | $761.9M | $927.3M | ||
| Q4 24 | $655.3M | $866.8M | ||
| Q3 24 | $438.5M | $916.0M | ||
| Q2 24 | $422.4M | $924.0M | ||
| Q1 24 | $404.3M | $925.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.73× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $24.8M |
| Free Cash FlowOCF − Capex | $69.0M | $24.1M |
| FCF MarginFCF / Revenue | 45.5% | 19.3% |
| Capex IntensityCapex / Revenue | 0.9% | 0.6% |
| Cash ConversionOCF / Net Profit | 5.95× | 0.15× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $24.8M | ||
| Q3 25 | $99.5M | $34.0M | ||
| Q2 25 | $27.3M | $30.7M | ||
| Q1 25 | $51.0M | $31.4M | ||
| Q4 24 | $54.0K | $22.1M | ||
| Q3 24 | $6.8M | $35.8M | ||
| Q2 24 | $13.3M | $28.6M | ||
| Q1 24 | $3.1M | $22.2M |
| Q4 25 | $69.0M | $24.1M | ||
| Q3 25 | $99.2M | $33.1M | ||
| Q2 25 | $26.5M | $30.2M | ||
| Q1 25 | $50.9M | $30.3M | ||
| Q4 24 | $-341.0K | $21.5M | ||
| Q3 24 | $6.2M | $35.1M | ||
| Q2 24 | $12.7M | $28.2M | ||
| Q1 24 | $2.3M | $21.2M |
| Q4 25 | 45.5% | 19.3% | ||
| Q3 25 | 37.0% | 26.8% | ||
| Q2 25 | 10.9% | 25.2% | ||
| Q1 25 | 24.0% | 24.9% | ||
| Q4 24 | -0.1% | 18.1% | ||
| Q3 24 | 7.8% | 30.3% | ||
| Q2 24 | 16.7% | 25.4% | ||
| Q1 24 | 3.4% | 19.1% |
| Q4 25 | 0.9% | 0.6% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.3% | 0.4% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.2% | 0.5% | ||
| Q3 24 | 0.8% | 0.5% | ||
| Q2 24 | 0.7% | 0.4% | ||
| Q1 24 | 1.1% | 0.9% |
| Q4 25 | 5.95× | 0.15× | ||
| Q3 25 | 1.80× | 3.55× | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
